跳至主要内容
临床试验/NCT07317440
NCT07317440尚未招募不适用

Coenzyme Q10 as an Adjunct Therapy in Pediatric Community-Acquired Pneumonia

Tanta University1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2025年12月31日最近更新:
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
120
试验地点
1
主要终点
Normalization of respiratory rate

研究概览

简要总结

The aim of this work is to assess the benefit of coenzyme Q10 supplementation, in addition to standard antibiotic and other supportive therapy, in the management of hospitalized children with community acquired pneumonia

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
2 Months 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • All children aged 2 months -18 years with community acquired pneumonia diagnosed by signs and symptoms of CAP including; chest pain, dyspnea, tachypnea, or abnormal auscultatory findings plus focal findings on chest x ray indicating community acquired pneumonia

排除标准

  • Children with immunodeficiency, chronic lung disease, malignancy, congenital lung anomalies, underlying disorder impacting respiration i.e. genetic, metabolic, neuromuscular disorders, children with CHD affecting the pulmonary blood flow.

研究组 & 干预措施

60 children with community acquired pneumonia will receive oral coenzymeQ10

Experimental

干预措施: oral coenzymeQ10 (Drug)

结局指标

主要结局

Normalization of respiratory rate

时间窗: 3 days

Normalization of oxygen saturation

时间窗: 3 days

Serum C-Reactive Protein (CRP) Level

时间窗: 5 days

Blood samples will be collected, and CRP concentration will be expressed in milligrams per liter (mg/L).

Normalization of temperature

时间窗: 3 days

Normalization of Feeding Behavior Assessed by Oral Intake Tolerance

时间窗: 3 days

Normalization of feeding refusal will be assessed by evaluating the child's ability to tolerate age-appropriate oral feeding without refusal over a 3-day observation period.

Serum Lactate Dehydrogenase (LDH) Level

时间窗: 5 days

LDH concentration will be reported in units per liter (U/L) from venous blood samples.

Prognostic Nutritional Index

时间窗: 5 days

Systemic Immune-Inflammation Index

时间窗: 5 days

Serum C-Reactive Protein to Albumin Ratio (CRP/Albumin Ratio)

时间窗: 5 days

The serum C-reactive protein to albumin ratio (CRP/albumin ratio) will be calculated as a single composite outcome measure using laboratory values obtained from the same blood sample.

Time of clinical stability

时间窗: 3-5 days

次要结局

  • Length of hospital stay(10-21 days)
  • Number of Participants Requiring Surgical Intervention(21-30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rehab Zaki Elmeazawy

Lecturer of pediatrics

Tanta University

研究点 (1)

Loading locations...

相似试验

Coenzyme Q10 in Pediatric Community-Acquired... | 临床试验